IL84862A - Synergistic treatment method for increasing the concentration of endogenous growth hormone - Google Patents

Synergistic treatment method for increasing the concentration of endogenous growth hormone

Info

Publication number
IL84862A
IL84862A IL84862A IL8486287A IL84862A IL 84862 A IL84862 A IL 84862A IL 84862 A IL84862 A IL 84862A IL 8486287 A IL8486287 A IL 8486287A IL 84862 A IL84862 A IL 84862A
Authority
IL
Israel
Prior art keywords
growth hormone
concentration
increasing
treatment method
endogenous growth
Prior art date
Application number
IL84862A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL84862A publication Critical patent/IL84862A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Processing Of Meat And Fish (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Disintegrating Or Milling (AREA)
  • Transplanting Machines (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
IL84862A 1986-12-22 1987-12-17 Synergistic treatment method for increasing the concentration of endogenous growth hormone IL84862A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94511486A 1986-12-22 1986-12-22

Publications (1)

Publication Number Publication Date
IL84862A true IL84862A (en) 1992-06-21

Family

ID=25482636

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84862A IL84862A (en) 1986-12-22 1987-12-17 Synergistic treatment method for increasing the concentration of endogenous growth hormone

Country Status (19)

Country Link
EP (1) EP0272890B1 (de)
JP (1) JP2533146B2 (de)
KR (1) KR960008652B1 (de)
CN (1) CN1032787C (de)
AT (1) ATE78172T1 (de)
AU (1) AU599180B2 (de)
CA (1) CA1313134C (de)
DE (1) DE3780431T2 (de)
DK (1) DK170758B1 (de)
ES (1) ES2044958T3 (de)
GR (1) GR3005638T3 (de)
HK (1) HK36493A (de)
HU (1) HU204703B (de)
IE (1) IE60086B1 (de)
IL (1) IL84862A (de)
NZ (1) NZ222983A (de)
PH (1) PH23492A (de)
PL (1) PL269527A1 (de)
ZA (1) ZA879527B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
FR2694885B1 (fr) * 1992-08-20 1994-10-07 Rhone Merieux Procédé pour améliorer la croissance et la qualité des carcasses des animaux domestiques producteurs de viande, ensemble de vaccination et vaccins.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2238476A1 (en) * 1973-07-23 1975-02-21 Aries Robert Double esters of zeranol and natural hormones - and their implants for livestock, have protein anabolism props
FR2240718A1 (en) * 1973-08-13 1975-03-14 Aries Robert Solid implants for increasing growth of animals - contg. hormones, esters or derivs

Also Published As

Publication number Publication date
DE3780431T2 (de) 1993-02-25
PH23492A (en) 1989-08-16
DE3780431D1 (de) 1992-08-20
ZA879527B (en) 1989-08-30
KR960008652B1 (en) 1996-06-28
EP0272890A2 (de) 1988-06-29
ES2044958T3 (es) 1994-01-16
CA1313134C (en) 1993-01-26
DK664787D0 (da) 1987-12-17
HK36493A (en) 1993-04-23
DK170758B1 (da) 1996-01-15
NZ222983A (en) 1990-04-26
CN87108176A (zh) 1988-07-13
CN1032787C (zh) 1996-09-18
IE60086B1 (en) 1994-06-01
HU204703B (en) 1992-02-28
AU599180B2 (en) 1990-07-12
IE873448L (en) 1988-06-22
ATE78172T1 (de) 1992-08-15
HUT56271A (en) 1991-08-28
JPS63166831A (ja) 1988-07-11
GR3005638T3 (de) 1993-06-07
JP2533146B2 (ja) 1996-09-11
AU8269987A (en) 1988-06-23
KR880007091A (ko) 1988-08-26
EP0272890B1 (de) 1992-07-15
PL269527A1 (en) 1988-10-13
EP0272890A3 (en) 1990-01-17
DK664787A (da) 1988-06-23

Similar Documents

Publication Publication Date Title
ES2005224A6 (es) Combinacion de polipeptidos para liberar y aumentar la hormona de crecimiento en la sangre de un animal.
AU7716787A (en) Perfusion and oxygen saturation in oximetry
IL75671A0 (en) Method and apparatus for pulsed administration of growth promoting agents
GB2212065B (en) One step dressing delivery system
EP0242643A3 (en) Nasal administration of drugs
GR880300077T1 (en) Galanthamine or analogues thereof for treating alzheimer's disease
ES8507567A1 (es) Metodo para estabilizar un concentrado de gamma globulina
EP0365779A3 (de) Cyclische GRF-II-Analoge
PH23492A (en) Synergistic treatment method
IL81809A (en) Method and compositions for increasing mammary parenchyma
IT8748116A0 (it) Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche
DE3766885D1 (en) Chlorpheniramine therapie.
ZA881751B (en) Porcine growth hormone analogs
NZ216122A (en) Stimulating ovulation in mares by administering gonadotrophin-releasing hormones
EP0389570A4 (en) High integrity liposomes and method of preration and use
HK35793A (en) Increasing endogenous growth hormone
EP0144489A3 (en) Cerebral and peripheral antihypoxidoticum
EP0092386A3 (en) Hydantoin therapeutic agents
GB2250690B (en) Device and method for depletion of the leukocyte content of blood and blood components
AU7931487A (en) Therapeutic treatment of abnormal cell growth with follicle regulatory protein
CS255786A1 (en) Method of steel components' complex diffusion saturation
PT82277A (en) Method for enhancement of absorption of proteins with medicinal properties
ZA887847B (en) Device and method for depletion of the leukocyte content of blood and blood components

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees